July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Surgical feasibility and biocompatibility of the OptoEpiret retinal stimulator
Author Affiliations & Notes
  • Tibor Karl Lohmann
    Department of Ophtalmology, RWTH Aachen University Hospital, Aachen, Germany
  • Claudia Werner
    Department of Ophtalmology, RWTH Aachen University Hospital, Aachen, Germany
  • Pascal Raffelberg
    Electronic Components and Circuits, University of Duisburg-Essen, Duisburg, Germany
  • Florian Waschkowski
    Institute of Materials in Electrical Engineering 1, RWTH Aachen University, Aachen, Germany
  • Reinhard Viga
    Electronic Components and Circuits, University of Duisburg-Essen, Duisburg, Germany
  • Rainer Kokozinski
    Electronic Components and Circuits, University of Duisburg-Essen, Duisburg, Germany
    Fraunhofer Institute of Microelectronic Circuits and Systems, Duisburg, Germany
  • Wilfried Mokwa
    Institute of Materials in Electrical Engineering 1, RWTH Aachen University, Aachen, Germany
  • Sandra Johnen
    Department of Ophtalmology, RWTH Aachen University Hospital, Aachen, Germany
  • Peter Walter
    Department of Ophtalmology, RWTH Aachen University Hospital, Aachen, Germany
  • Kim Schaffrath
    Department of Ophtalmology, RWTH Aachen University Hospital, Aachen, Germany
  • Footnotes
    Commercial Relationships   Tibor Lohmann, None; Claudia Werner, None; Pascal Raffelberg, None; Florian Waschkowski, None; Reinhard Viga, None; Rainer Kokozinski, None; Wilfried Mokwa, None; Sandra Johnen, None; Peter Walter, None; Kim Schaffrath, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 4982. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tibor Karl Lohmann, Claudia Werner, Pascal Raffelberg, Florian Waschkowski, Reinhard Viga, Rainer Kokozinski, Wilfried Mokwa, Sandra Johnen, Peter Walter, Kim Schaffrath; Surgical feasibility and biocompatibility of the OptoEpiret retinal stimulator. Invest. Ophthalmol. Vis. Sci. 2019;60(9):4982.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Degenerative retinal diseases, i.e. retinitis pigmentosa, cause a severe decline of the visual function up to blindness. To this day treating these diseases remains difficult. One way of conquering the eminent loss of vision is implanting retinal prostheses.
In this study we investigated the surgical feasibility and biocompatibility of the newly developed OptoEpiret retinal stimulator.

Methods : The OptoEpiret retinal stimulator combines aspects of former projects of our group (epiretinal stimulation [EpiRet3], large stimulating array [VLARS]) and extends the functional range by adding an integrated circuit (IC) based optical capturing system. This solution allows capturing of visual information, visual processing, computing of a stimulus pattern and stimulating the ganglion cell layer all on the implanted 9mm array.
In order to investigate the surgical feasibility and biocompatibility our group firstly established an implantation surgery by implanting the OptoEpiret in two cadaveric rabbit eyes. Afterwards the implantation method was transferred into an in-vivo model by implanting inactive arrays in 6 rabbits. In an 8 week follow-up, the rabbits were tested clinically and received funduscopic imaging and OCT-imaging, if possible. After concluding the follow up, histological examination, as well as resin-embedding and thin-slicing of the eyes was performed.

Results : The implantation surgery conducted in the cadaveric eyes included phacoemulsification, vitrectomy and insertion of the OptoEpiret array through a 5mm corneal incision. The array was fixated on the retinal pole with a central retinal tack. The procedure was deemed safe and transferred to the in-vivo setting. As main adverse effects, we encountered vitreal hemorrhage, retinal tearing or detachment and difficulties of retinal fixation of the large array. In the follow up, transitional corneal edema caused difficulties in post-surgical imaging. In histological examination gliosis around the area of retinal fixation and mild signs of inflammation were detected.

Conclusions : Findings in the implantation surgery lead to the assumption that the OptoEpiret retinal stimulator’s implantation surgery is safe and feasible. The follow-up examinations showed good biocompatibility. In further experiments, the functional capabilities will be examined by implanting active devices in an acute setting.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×